The combined use of prostaglandin and antiprogestin in human fertility control.
Baulieu
E E
EE
Lab, Hormones, INSERM U 33, Collège de France, Le Kremlin-Bicêtre.
D000019:Abortifacient Agents / Q000494:pharmacology*; D000028:Abortion, Induced; D003270:Contraceptive Agents; D004347:Drug Interactions; D005260:Female; D005298:Fertility / Q000187:drug effects*; D006801:Humans; D015735:Mifepristone / Q000494:pharmacology*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011372:Progestins / Q000037:antagonists & inhibitors*; D011453:Prostaglandins / Q000494:pharmacology*; D014590:Uterine Contraction / Q000187:drug effects
D000019:Abortifacient Agents; D003270:Contraceptive Agents; D011372:Progestins; D011453:Prostaglandins; D015735:Mifepristone